Drawing for WE MANAGE THE SCIENCE THAT MANAGES CANCER

USPTO serial 76029145

WE MANAGE THE SCIENCE THAT MANAGES CANCER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
MILTON, PRISCILLA
Law office
FILE REPOSITORY (FRANCONIA)

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with WE MANAGE THE SCIENCE THAT MANAGES CANCER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven J. Wadyka, Jr.

STEVEN J WADYKA JR GREENBERG TRAURIG1750 TYSON BLVDSTE 1200MCLEAN, VA 22102

Goods and services

ClassDescriptionStatusFirst use
016Printed matter, namely, business promotional materials in the nature of brochures, newsletters, information reports, prospectuses and the like for generating new business opportunities and maintaining existing business relationships and featuring business information on the pharmaceutical industry, pharmaceuticals and pharmaceutical research, scientific industry and the field of medicine, discovery and developmentACTIVE
042business promotional materials provided on line for generating new business opportunities and maintaining existing business relationships and featuring business information on the pharmaceutical industry, pharmaceuticals and pharmaceutical research, scientific industry and the field of medicine, discovery and developmentINACTIVE - INSUFFICIENT FEE RECEIVED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
May 7, 2002ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 5, 2002DOCKASSIGNED TO EXAMINER
Aug 8, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2001CNSLLETTER OF SUSPENSION MAILED
Mar 29, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 27, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance